Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery


Autoria(s): Guo SJ; Li D; Zhang LM; Li J; Wang EK
Data(s)

2009

Resumo

In this contribution, we report a facile, gram-scale, low-cost route to prepare monodisperse superparamagnetic single-crystal magnetite NPs with mesoporous structure (MSSMN) via a very simple solvothermal method. The formation mechanism of MSSMN is also discussed and we think that Ostwald ripening probably plays an important role in this synthesis process. It is also interestingly found that the size and morphology of mesoporous Fe3O4 NPs can be easily controlled by changing the amount of NaOH and 1,2-ethylenediamine (ETH). Most importantly, the MSSMN can be used as an effective drug delivery carrier. A typical anticancer drug, doxorubicin (Dox), is used for drug loading, and the release behaviors of Dox in two different pH solutions are studied. The results indicate that the MSSMN has a high drug loading capacity and favorable release property for Dox; thus, it is very promising for the application in drug delivery.

Identificador

http://202.98.16.49/handle/322003/12187

http://www.irgrid.ac.cn/handle/1471x/148506

Idioma(s)

英语

Fonte

Guo SJ;Li D;Zhang LM;Li J;Wang EK.Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery,BIOMATERIALS ,2009,30(10):1881-1889

Palavras-Chave #IRON-OXIDE NANOPARTICLES #ONE-POT SYNTHESIS #IN-VIVO #NANOCRYSTALS #THERAPY #NANOSTRUCTURES #PARTICLES #VESICLES #CANCER #PHASE
Tipo

期刊论文